🏅 FDA Orphan Designation
ICATIBANT
ICATIBANT ACETATE
Manufacturer: Bryant Ranch Prepack
Indicated for:
FDA-Approved Indications (1)
indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older
Population: adults 18 years of age and older
Indications & Usage
1 INDICATIONS AND USAGE Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. Icatibant injection is a bradykinin B2 receptor antagonist indicated for treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. ( 1 )
💙 Support Programs
View all →ICATIBANT
Bryant Ranch Prepack
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.